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INTRODUCTION
Obesity increases the prevalence and severity of asthma in 
children and has a negative impact on the efficacy of conven-
tional asthma therapy; however, the mechanism of the associa-
tion between obesity and asthma is not clear.
1-3 Changes in lung 
volume, including tidal volume due to obesity; the inflammato-
ry effects of adipose tissue hormones and cytokines such as 
leptin, adiponectin, tumor necrosis factor (TNF) and interleu-
kin (IL)-6; and conditions such as gastroesophageal reflux and 
sleep-disordered breathing associated with obesity have been 
implicated in the association between obesity and asthma.
2,4 
The disruption of immune tolerance mechanisms by obesity-
associated adipokines and cytokines has been demonstrated to 
be involved in the association of obesity with asthma and auto-
immune diseases.
4
Leptin, adiponectin, and ghrelin are important mediators of 
energy metabolism and have been reported to have pro- or an-
ti-inflammatory functions.
5-8 Serum levels of leptin are increased 
in obesity, whereas those of adiponectin and ghrelin are de-
creased.
5-8 Increased leptin levels lead to the downregulation of 
regulatory T cells, and the decrease in adiponectin causes the 
downregulation of IL-10 secretion.
4 The reduction of serum 
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ghrelin levels with obesity represses IL-1β, IL-6, and TNF-α lev-
els, further disrupting anti-inflammatory mechanisms.
9 The 
main outcome of these obesity-associated changes is a hyper-
reactive immune system, which is susceptible to the develop-
ment of allergic and autoimmune diseases.
4
The aim of this study was to evaluate the levels of three hor-
mones of energy metabolism (leptin, ghrelin, and adipokine) in 
obese and non-obese children with asthma and in healthy chil-
dren without asthma, and to investigate the association between 
these levels and clinical outcome. 
MATERIALS AND METHODS 
Subjects
This study included 91 children (40 obese and 51 non-obese) 
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Purpose:  The aim of this study was to evaluate serum levels of leptin, ghrelin, and adiponectin in obese and non-obese children with asthma and 
in healthy non-asthmatic children, and analyze their relationships with clinical outcomes.  Methods:  This study enrolled 40 obese and 51 non-obese 
children with asthma and 20 healthy children. Body mass index and serum leptin, ghrelin, and adiponectin levels were determined in all children. Asth-
ma symptom scores and lung function test results were recorded for subjects with asthma.  Results:  Serum leptin levels (11.8±7.9, 5.3±6.8, and 
2.1±2.4 ng/mL in the obese asthmatic, non-obese asthmatic, and control groups, respectively) and adiponectin levels (12,586.2±3,724.1; 18,089.3±
6,452.3; and 20,297.5±3,680.7 ng/mL, respectively) differed significantly among the groups (P<0.001 for all). Mean ghrelin levels were 196.1±96.8 
and 311.9±352.8 pg/mL in the obese and non-obese asthmatic groups, respectively, and 348.8±146.4 pg/mL in the control group (P=0.001). The 
asthma symptom score was significantly higher in the obese children with asthma than in the non-obese children with asthma (P<0.001). Leptin and 
adiponectin levels were correlated with the asthma symptom score in non-obese children with asthma (r=0.34 and r=-0.62, respectively).  Conclu-
sions:  Obesity leads to more severe asthma symptoms in children. Moreover, leptin, adiponectin, and ghrelin may play important roles in the in-
flammatory pathogenesis of asthma and obesity co-morbidity. 
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with new-onset moderate asthma and 20 children without 
asthma. In accordance with the guidelines of the Global Initia-
tive for Asthma, asthma was diagnosed based on a history of re-
current or chronic chest symptoms such as cough, wheezing, 
difficult breathing, and chest tightness that demonstrated clini-
cal reversibility with short-acting bronchodilator treatment.
10 
The children with asthma had not received anti-inflammatory 
treatment.
Children with any other acute or chronic disease, including 
acute upper or lower respiratory tract infection, were excluded, 
as were children who had received treatment for asthma within 
the previous 3 months. 
The children with asthma were grouped as obese and non-
obese according to their body mass index (BMI) percentile, 
where obesity was defined as a BMI greater than the 95th per-
centile for age and gender.
11,12 The BMI was calculated accord-
ing to the formula: weight (kg)/height
2 (m
2).
Study design
Sociodemographic characteristics of the children, including 
age and gender, were recorded. Height and weight were mea-
sured using a stadiometer and an electronic scale, respectively, 
under the supervision of the researchers. Asthma symptom 
scores were assessed and recorded for the children with asth-
ma. Serum leptin, ghrelin, and adiponectin levels were mea-
sured in fasting serum samples obtained in early morning. The 
study was approved by the university ethics committee; in-
formed consent was obtained from the parents of the children.
Determination of symptom scores 
Symptom scores in children with asthma were assessed ac-
cording to a six-domain asthma symptom score.
13 The items in 
the scale included dyspnea, tightness in the chest, wheezing 
during the day, wheezing during the night, and daily perfor-
mance, scored from zero to three based on severity. 
Blood sampling
For the measurement of leptin, ghrelin, and adiponectin lev-
els, venous blood (2 mL) was obtained at 9:00 a.m. after an over-
night fast. Blood samples were allowed to clot at room temper-
ature for 60 minutes. The serum was separated by centrifuga-
tion at 1,200×g for 10 minutes and stored at -80°C. Sera were 
thawed at room temperature before measurements. 
Measurement of serum leptin, ghrelin, and adiponectin
The serum leptin concentration was determined using a dou-
ble antibody sandwich ELISA method with an antibody specif-
ic for human leptin (Biosource Leptin ELISA kit KAP2281; Bio-
source Europe S.A., Nivelles, Belgium). The assay sensitivity was 
0.1 ng/mL, and the intra-assay %CV was 3.6. 
The serum ghrelin concentration was measured using a dou-
ble antibody sandwich ELISA method with an antibody specif-
ic for human ghrelin (Desacyl-Ghrelin ELISA kit; Linco Research 
Inc., St. Charles, MO, USA). The assay sensitivity was 12.5 mmol/
mL, the inter-assay %CV was 8.6, and the intra-assay %CV was 
3.6. 
The serum adiponectin concentration measured by the dou-
ble antibody sandwich ELISA method with an antibody specif-
ic for human adiponectin (Linco Research Inc.). The assay sen-
sitivity was 0.78 ng/mL, the inter-assay %CV was 8.4, and the 
intra-assay %CV was 7.4. 
Statistical analysis 
Statistical analyses were performed using the SPSS software 
package, version 13.0 for Windows (SPSS, Chicago, IL, USA). 
Values of P<0.05 were taken to indicate significance. A Krus-
kall-Wallis test was used to compare leptin, ghrelin, and adipo-
nectin levels and the mean age among the three groups. Fre-
quencies were compared with a Chi-square test. The relation-
ships between the adipokine levels and asthma severity param-
eters were examined using Pearson’s correlation analysis.
RESULTS
Demographic and disease characteristics of the subjects
The mean ages of the obese children with asthma (n=40), 
non-obese children with asthma (n=51), and control children 
(n=20) were 9.3±2.1, 10.4±2.7, and 10.7±2.9 years, respec-
tively (P=0.03). Males constituted 55, 56.9, and 45% of the re-
spective groups (P=0.66) (Table 1). 
The BMI and abdominal circumference were significantly 
greater in the obese group than in the non-obese or control 
Table 1.  Demographic characteristics of the children included in the study
Characteristic
Obese 
asthmatic 
n=40 
Non-obese 
asthmatic 
n=51
Healthy 
controls 
n=20
P
Age (mean±SD) 9.3±2.1 10.4±2.7 10.7±2.9 0.06
Gender, n
Male 22 29 9 0.66
Female 18 22 11
Table 2.  BMI, lung function test results, and symptom scores in the study 
groups
Parameter Obese 
asthmatic
Non-obese 
asthmatic
Healthy 
controls
P
BMI 25.1±6.8 18.6±2.8 18.1±3.2 <0.001 
Symptom score 10.9±2.8 8.2±2.9 - <0.001
FEV1 91.4±13.8 93.8±15.1 - 0.69
FVC 86.5±11.3 85.9±14.3 - 0.92
PEF 67.8±22.0 72.9±15.2 - 0.44
BMI, body mass index.Yuksel et al.
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groups (P<0.001) (Table 2). The mean asthma symptom score 
was significantly higher in the obese children with asthma than 
in the non-obese children with asthma (10.9±2.8 vs. 8.2±2.9; 
P<0.001) (Table 2; Fig. 1).
Lung function test results were not significantly different be-
tween the obese and non-obese children with asthma (P>0.05 
for FEV1, FVC, and PEF) (Table 2).
Serum leptin, ghrelin, and adiponectin levels
The serum leptin level differed significantly (P<0.001) among 
the obese asthmatic (11.8±7.9 ng/mL), non-obese asthmatic 
(5.3±6.8 ng/mL), and control groups (2.1±2.4 ng/mL) (Fig. 2). 
The serum adiponectin level also differed significantly (P<
0.001) among the obese asthmatic (12,586.2±3,724.1 ng/mL), 
non-obese asthmatic (18,089.3±6,452.3 ng/mL), and control 
groups (20,297.5±3,680.7 ng/mL) (Fig. 3). The serum ghrelin 
levels in the obese and non-obese asthmatic groups were 196.1±
96.8 and 311.9±352.8 pg/mL, respectively, and the level in the 
control group was 348.8±146.4 pg/mL (P=0.001) (Fig. 4). 
Correlation between serum adipokine levels and clinical 
outcome
In the non-obese group, the leptin level was significantly cor-
related with age, BMI, and abdominal circumference (r=0.42, 
0.68, and 0.67, respectively). The leptin level showed a signifi-
cant negative correlation with the adiponectin level (r=-0.32), 
but not with the ghrelin level (r=-0.09). The leptin level also 
had a significant positive correlation with the symptom score 
(r=0.34), while the symptom score and adiponectin level were 
significantly negatively correlated (r=-0.62), and the symptom 
score and ghrelin level were not significantly correlated (r=
-0.12).
In the obese group, the leptin level was not correlated with 
any of the sociodemographic characteristics, including age, BMI, 
and symptom score (P>0.05 for all). The leptin level was also 
not correlated with the adiponectin or ghrelin level (r=-0.09, 
and 0.11, respectively), and neither the adiponectin nor ghrelin 
level was correlated with any of the disease severity parameters 
Fig. 1.  Symptom scores of obese and non-obese children with asthma.
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Fig. 2.  Serum leptin levels (ng/mL) of the study groups. 
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Fig. 3.  Serum adiponectin levels (ng/mL) of the study groups. 
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Fig. 4.  Serum ghrelin levels (pg/mL) of the study groups.
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(P>0.05). 
In the control group, the leptin, adiponectin, and ghrelin lev-
els were not significantly correlated with each other or with age 
or BMI (P>0.05). 
DISCUSSION
There is a trend toward an increasing frequency of both obesi-
ty and asthma in the modern world, and elucidation of the 
pathogenic mechanism of the association between these two 
entities may aid in resolving therapeutic failure in obese chil-
dren with asthma.
1,2 Several mechanisms have been proposed, 
including a common etiological background such as fetal pro-
gramming, worsening of asthma due to co-morbid conditions 
of obesity such as gastroesophageal reflux disease, and the in-
fluence of obesity on lung mechanics such as decreased tidal 
volume.
2,3 Recently, hormones and cytokines released from ad-
ipose tissue, especially adipokines and ghrelin, have been the 
focus of research regarding this association.
2,3,14 Our data dem-
onstrate increased leptin levels in asthmatic children, and this 
increase was more prominent in obese children. Additionally, 
adiponectin and ghrelin levels were lower in obese than non-
obese children with asthma. All of these data favor the hypoth-
esis that adipokines play important roles in the inflammatory 
pathogenesis of asthma in obese individuals.
Leptin, a hormone of adipose tissue, is associated with in-
flammation,
2 and its levels have been shown to be higher in 
children with asthma than in those without asthma.
15,16 Leptin 
is a regulator of T cell proliferation and activation, monocyte re-
cruitment and activation, and angiogenesis.
17 Moreover, it plays 
a role in normal lung development.
18 It has been shown to mod-
ulate the allergic airway response independent of obesity and 
to enhance the airway inflammatory response leading to high-
er antigen-induced T cell responses, increased mitogen-induced 
splenocyte interferon-γ production, and an increased number 
of tracheal mast cells.
19,20 Our data indicate that leptin levels were 
significantly higher in obese and non-obese children with asth-
ma than in healthy controls. This suggests a role of leptin as an 
inflammatory mediator in asthma, in concordance with previ-
ous reports of the inflammatory characteristics of this adipo-
kine.
19,20 Moreover, the higher leptin levels in obese children 
with asthma might have contributed to their higher symptom 
scores, compared with non-obese children with asthma.
Despite the higher symptom scores in obese compared with 
non-obese children with asthma, the leptin levels in obese chil-
dren were not correlated with the asthma symptom scores. In 
contrast, leptin levels demonstrated a significant correlation 
with symptom scores in non-obese children with asthma. The 
absence of this correlation in obese children with asthma was 
attributed to the influence of obesity on leptin levels, such that 
the importance of obesity in determining leptin levels might 
have masked the presence of a correlation. However, it is more 
likely that a correlation was demonstrated in non-obese chil-
dren with asthma because leptin plays a role in the inflamma-
tory response in these children.
Adiponectin, similar to leptin, influences energy metabolism, 
but it has anti-inflammatory effects.
5 Adiponectin is negatively 
associated with obesity because its concentration increases with 
weight loss.
21 The decrease of adiponectin in obesity may be re-
lated to the association between obesity and asthma,
5,22 as aller-
gen challenge leads to less airway responsiveness and inflam-
mation in animal models with higher adiponectin levels.
5 
Moreover, adiponectin inhibits the proliferation of cultured 
vascular smooth muscle cells.
23 If adiponectin were to have a 
similar influence on airway smooth muscle, the decrease in ad-
iponectin in obese individuals could contribute to increased 
smooth muscle mass in asthmatic individuals.
24 The lower adi-
ponectin levels in obese compared with non-obese children 
with asthma and the lower adiponectin levels in non-obese 
children with asthma compared with controls in the present 
study support an anti-inflammatory role for this adipokine. 
Ghrelin is a gastric hormone that increases appetite and de-
creases fat utilization, playing a role in both short- and long-
term regulation of energy balance.
5,25 Ghrelin levels change in 
response to dieting to maintain body weight.
26 There is little in-
formation available regarding ghrelin levels in obese asthmat-
ics. A recent study showed that IgE levels are inversely correlat-
ed with ghrelin levels in obese children, leading the authors to 
postulate that ghrelin directly or indirectly inhibits IgE synthe-
sis.
27 Moreover, acting via its receptor, growth hormone secreta-
gogue receptor (GHS-R),
9 ghrelin has immuno-modulatory ac-
tivities that contradict those of leptin.
28 Ghrelin exerts anti-in-
flammatory actions primarily through dose- and time-depen-
dent inhibition of IL-1β, IL-6, and TNF-α.
9 It also decreases the 
leptin-induced pro-inflammatory response in mononuclear 
and T cells.
9 However, no association could be found between 
the levels of interferon-γ-secreting T cells and ghrelin levels in 
obese children.
29 Here, we report lower ghrelin levels in obese 
children with asthma than in non-obese children with asthma 
or controls, and lower ghrelin levels in non-obese children with 
asthma than in control subjects. These results support an anti-
inflammatory role of ghrelin in the pathogenesis of asthma and 
obesity. 
When compared with the non-obese asthmatic children, the 
obese children with asthma had more days of absenteeism from 
school, lower peak expiratory flow, more asthma drug prescrip-
tions, and more emergency department visits.
30 A linear rela-
tionship between asthma severity and BMI has been pro-
posed.
31,32 Although some research has demonstrated that asth-
ma is more difficult to control in obese individuals, other stud-
ies were unable to demonstrate an association between obesity 
and asthma severity in children with mild asthma.33 Similar to 
these reports, the symptom scores of the obese children with 
asthma in our study were significantly higher than those of non-Yuksel et al.
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obese children with asthma.
The major limitation of this study was the absence of an eval-
uation of adipokine levels and asthma severity in the obese 
children with asthma after a weight loss intervention. This might 
have demonstrated a change in adipokine levels with weight 
loss, allowed an examination of the change in asthma control 
with altered adipokine levels, and enabled the determination of 
a causal relationship between adipokine levels and asthma se-
verity. Moreover, measurement of an indicator of inflammation 
such as FeNO would have contributed to our understanding of 
the relationship between adipokine levels and inflammation in 
asthma. Another limitation is the small number of children en-
rolled, which decreased the power of the study. 
In conclusion, the results of this study indicate that serum 
leptin is increased while serum adiponectin and ghrelin are de-
creased in children with asthma compared with non-asthmatic 
children. Moreover, the increase in leptin and decreases in adi-
ponectin and ghrelin are more prominent in obese than in non-
obese children with asthma. These data suggest that adipokines 
such as leptin, Adiponectin, and ghrelin are important in the 
inflammatory pathogenesis of the co-morbidity of asthma and 
obesity. 
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